 | WSM | Name: | 4-(3-aminopropyl)-2H-1,4-benzoxazin-3(4H)-one | Formula: | C11 H14 N2 O2 | SMILES: | NCCCN2c1c(cccc1)OCC2=O | InChi: | InChI=1S/C11H14N2O2/c12-6-3-7-13-9-4-1-2-5-10(9)15-8-11(13)14/h1-2,4-5H,3,6-8,12H2 | Definition date: | 2020-11-04 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 4-(3-aminopropyl)-2H-1,4-benzoxazin-3(4H)-one |
|
 | WSY | Name: | 3-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)propanoic acid | Formula: | C7 H11 N3 O2 | SMILES: | n1(CCC(=O)O)c(C)nc(n1)C | InChi: | InChI=1S/C7H11N3O2/c1-5-8-6(2)10(9-5)4-3-7(11)12/h3-4H2,1-2H3,(H,11,12) | Definition date: | 2020-11-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 3-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)propanoic acid |
|
 | X2G | Name: | 4-{3-[(E)-2-cyanoethenyl]-5-fluorophenoxy}-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate | Formula: | C21 H15 F2 N3 O7 S | SMILES: | [C@H](=CC#N)c1cc(cc(c1)Oc2ccc(cc2OCCN3C(NC(=O)C=C3)=O)OS(=O)(=O)F)F | InChi: | InChI=1S/C21H15F2N3O7S/c22-15-10-14(2-1-6-24)11-17(12-15)32-18-4-3-16(33-34(23,29)30)13-19(18)31-9-8-26-7-5-20(27)25-21(26)28/h1-5,7,10-13H,8-9H2,(H,25,27,28)/b2-1+ | Definition date: | 2020-11-23 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 4-{3-[(E)-2-cyanoethenyl]-5-fluorophenoxy}-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate |
|
 | X2J | Name: | 4-{3-chloro-5-[(E)-2-cyanoethenyl]phenoxy}-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate | Formula: | C21 H15 Cl F N3 O7 S | SMILES: | [C@H](C#N)=Cc1cc(cc(c1)Oc2ccc(cc2OCCN3C(NC(=O)C=C3)=O)OS(=O)(=O)F)Cl | InChi: | InChI=1S/C21H15ClFN3O7S/c22-15-10-14(2-1-6-24)11-17(12-15)32-18-4-3-16(33-34(23,29)30)13-19(18)31-9-8-26-7-5-20(27)25-21(26)28/h1-5,7,10-13H,8-9H2,(H,25,27,28)/b2-1+ | Definition date: | 2020-11-23 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 4-{3-chloro-5-[(E)-2-cyanoethenyl]phenoxy}-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate |
|
 | X2S | Name: | 4-(3-chloro-5-cyanophenoxy)-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate | Formula: | C19 H13 Cl F N3 O7 S | SMILES: | N#Cc3cc(Oc1c(cc(cc1)OS(=O)(=O)F)OCCN2C=CC(=O)NC2=O)cc(c3)Cl | InChi: | InChI=1S/C19H13ClFN3O7S/c20-13-7-12(11-22)8-15(9-13)30-16-2-1-14(31-32(21,27)28)10-17(16)29-6-5-24-4-3-18(25)23-19(24)26/h1-4,7-10H,5-6H2,(H,23,25,26) | Definition date: | 2020-11-23 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 4-(3-chloro-5-cyanophenoxy)-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate |
|
 | X2V | Name: | 4-[(6-cyanonaphthalen-1-yl)oxy]-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate | Formula: | C23 H16 F N3 O7 S | SMILES: | c4(C#N)ccc1c(cccc1Oc2ccc(cc2OCCN3C=CC(=O)NC3=O)OS(F)(=O)=O)c4 | InChi: | InChI=1S/C23H16FN3O7S/c24-35(30,31)34-17-5-7-20(21(13-17)32-11-10-27-9-8-22(28)26-23(27)29)33-19-3-1-2-16-12-15(14-25)4-6-18(16)19/h1-9,12-13H,10-11H2,(H,26,28,29) | Definition date: | 2020-11-23 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 4-[(6-cyanonaphthalen-1-yl)oxy]-3-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenyl sulfurofluoridate |
|
 | SYQ | Name: | (S)-N-(1-cyclopropylethyl)-6-methylpicolinamide | Formula: | C12 H16 N2 O | SMILES: | C[CH](NC(=O)c1cccc(C)n1)C2CC2 | InChi: | InChI=1S/C12H16N2O/c1-8-4-3-5-11(13-8)12(15)14-9(2)10-6-7-10/h3-5,9-10H,6-7H2,1-2H3,(H,14,15)/t9-/m0/s1 | Synonyms: | ~{N}-[(1~{S})-1-cyclopropylethyl]-6-methyl-pyridine-2-carboxamide | Definition date: | 2020-12-07 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | ~{N}-[(1~{S})-1-cyclopropylethyl]-6-methyl-pyridine-2-carboxamide |
|
 | D7I | Name: | 5,5'-(ethane-1,2-diylbis(oxy))bis(benzene-5,4,2,1,-tetrayl)hexakisphosphate | Formula: | C14 H20 O26 P6 | SMILES: | O[P](O)(=O)Oc1cc(O[P](O)(O)=O)c(O[P](O)(O)=O)cc1OCCOc2cc(O[P](O)(O)=O)c(O[P](O)(O)=O)cc2O[P](O)(O)=O | InChi: | InChI=1S/C14H20O26P6/c15-41(16,17)35-9-5-13(39-45(27,28)29)11(37-43(21,22)23)3-7(9)33-1-2-34-8-4-12(38-44(24,25)26)14(40-46(30,31)32)6-10(8)36-42(18,19)20/h3-6H,1-2H2,(H2,15,16,17)(H2,18,19,20)(H2,21,22,23)(H2,24,25,26)(H2,27,28,29)(H2,30,31,32) | Definition date: | 2019-09-04 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | [2,4-diphosphonooxy-5-[2-(2,4,5-triphosphonooxyphenoxy)ethoxy]phenyl] dihydrogen phosphate |
|
 | T2K | Name: | 3-[5-[3,5-bis(chloranyl)phenyl]-4-phenyl-1,3-oxazol-2-yl]propanoic acid | Formula: | C18 H13 Cl2 N O3 | SMILES: | OC(=O)CCc1oc(c2cc(Cl)cc(Cl)c2)c(n1)c3ccccc3 | InChi: | InChI=1S/C18H13Cl2NO3/c19-13-8-12(9-14(20)10-13)18-17(11-4-2-1-3-5-11)21-15(24-18)6-7-16(22)23/h1-5,8-10H,6-7H2,(H,22,23) | Definition date: | 2020-12-13 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 3-[5-[3,5-bis(chloranyl)phenyl]-4-phenyl-1,3-oxazol-2-yl]propanoic acid |
|
 | D84 | Name: | 5-(1-{[2-(difluoromethoxy)phenyl]methyl}-2-{[3-(2-oxopyrrolidin-1-yl)phenoxy]methyl}-1H-benzimidazol-6-yl)pyridin-2(1H)-one | Formula: | C31 H26 F2 N4 O4 | SMILES: | c1(cc(ccc1)N2CCCC2=O)OCc5n(c4cc(C3=CNC(=O)C=C3)ccc4n5)Cc6c(cccc6)OC(F)F | InChi: | InChI=1S/C31H26F2N4O4/c32-31(33)41-27-8-2-1-5-22(27)18-37-26-15-20(21-11-13-29(38)34-17-21)10-12-25(26)35-28(37)19-40-24-7-3-6-23(16-24)36-14-4-9-30(36)39/h1-3,5-8,10-13,15-17,31H,4,9,14,18-19H2,(H,34,38) | Definition date: | 2017-10-23 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 5-(1-{[2-(difluoromethoxy)phenyl]methyl}-2-{[3-(2-oxopyrrolidin-1-yl)phenoxy]methyl}-1H-benzimidazol-6-yl)pyridin-2(1H)-one |
|
 | T3Z | Name: | (R)-N-(1-cyclopropylethyl)-6-methylpicolinamide | Formula: | C12 H16 N2 O | SMILES: | C[CH](NC(=O)c1cccc(C)n1)C2CC2 | InChi: | InChI=1S/C12H16N2O/c1-8-4-3-5-11(13-8)12(15)14-9(2)10-6-7-10/h3-5,9-10H,6-7H2,1-2H3,(H,14,15)/t9-/m1/s1 | Synonyms: | ~{N}-[(1~{R})-1-cyclopropylethyl]-6-methyl-pyridine-2-carboxamide | Definition date: | 2020-12-14 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | ~{N}-[(1~{R})-1-cyclopropylethyl]-6-methyl-pyridine-2-carboxamide |
|
 | XLP | Name: | 1,3-benzothiazole-6-carboxylic acid | Formula: | C8 H5 N O2 S | SMILES: | n1csc2cc(C(O)=O)ccc12 | InChi: | InChI=1S/C8H5NO2S/c10-8(11)5-1-2-6-7(3-5)12-4-9-6/h1-4H,(H,10,11) | Definition date: | 2020-12-18 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 1,3-benzothiazole-6-carboxylic acid |
|
 | XLV | Name: | 3,4-dimethyl-1,2-oxazol-5-amine | Formula: | C5 H8 N2 O | SMILES: | n1oc(N)c(C)c1C | InChi: | InChI=1S/C5H8N2O/c1-3-4(2)7-8-5(3)6/h6H2,1-2H3 | Definition date: | 2020-12-18 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 3,4-dimethyl-1,2-oxazol-5-amine |
|
 | XLY | Name: | (3R)-3-methyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one | Formula: | C10 H12 N2 O | SMILES: | N2C(c1ccccc1NCC2C)=O | InChi: | InChI=1S/C10H12N2O/c1-7-6-11-9-5-3-2-4-8(9)10(13)12-7/h2-5,7,11H,6H2,1H3,(H,12,13) | Definition date: | 2020-12-18 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | (3R)-3-methyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one |
|
 | XM4 | Name: | N-(4-chloro-2-methylphenyl)acetamide | Formula: | C9 H10 Cl N O | SMILES: | N(c1ccc(cc1C)Cl)C(C)=O | InChi: | InChI=1S/C9H10ClNO/c1-6-5-8(10)3-4-9(6)11-7(2)12/h3-5H,1-2H3,(H,11,12) | Definition date: | 2020-12-18 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | N-(4-chloro-2-methylphenyl)acetamide |
|
 | EJC | Name: | 5-propoxy-1H-indole | Formula: | C11 H13 N O | SMILES: | CCCOc1ccc2[nH]ccc2c1 | InChi: | InChI=1S/C11H13NO/c1-2-7-13-10-3-4-11-9(8-10)5-6-12-11/h3-6,8,12H,2,7H2,1H3 | Definition date: | 2020-01-07 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 5-propoxy-1~{H}-indole |
|
 | EL9 | Name: | cyclometalated-carbene platinum(II) complex | Formula: | C20 H15 F2 N4 Pt | SMILES: | CN1CN(C=C1)c2ccccn2.Fc3cc(F)c(c([Pt])c3)c4ccccn4 | InChi: | InChI=1S/C11H6F2N.C9H10N3.Pt/c12-8-4-5-9(10(13)7-8)11-3-1-2-6-14-11 | Definition date: | 2020-01-10 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
 | EN3 | Name: | (E)-15,22-Dioxa-4,11-diaza-5(2,5)-thiadiazola-10(3,6)-pyridazina-1,14(1,3)-dibenzenacyclodocosaphan-18-ene-3,12-dione | Formula: | C32 H34 N6 O4 S | SMILES: | O=C1Cc2cccc(OCCC=CCCOc3cccc(CC(=O)Nc4ccc(CCCCc5sc(N1)nn5)nn4)c3)c2 | InChi: | InChI=1S/C32H34N6O4S/c39-29-21-23-9-7-12-26(19-23)41-17-5-1-2-6-18-42-27-13-8-10-24(20-27)22-30(40)34-32-38-37-31(43-32)14-4-3-11-25-15-16-28(33-29)36-35-25/h1-2,7-10,12-13,15-16,19-20H,3-6,11,14,17-18,21-22H2,(H,33,36,39)(H,34,38,40)/b2-1+ | Definition date: | 2020-01-16 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
 | EOR | Name: | 2-[[6-(dimethylamino)-1,3-benzodioxol-5-yl]sulfanyl]-1-[2-(2,2-dimethylpropylamino)ethyl]imidazo[4,5-c]pyridin-4-amine | Formula: | C22 H30 N6 O2 S | SMILES: | CN(C)c1cc2OCOc2cc1Sc3nc4c(N)nccc4n3CCNCC(C)(C)C | InChi: | InChI=1S/C22H30N6O2S/c1-22(2,3)12-24-8-9-28-14-6-7-25-20(23)19(14)26-21(28)31-18-11-17-16(29-13-30-17)10-15(18)27(4)5/h6-7,10-11,24H,8-9,12-13H2,1-5H3,(H2,23,25) | Definition date: | 2020-01-17 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 2-[[6-(dimethylamino)-1,3-benzodioxol-5-yl]sulfanyl]-1-[2-(2,2-dimethylpropylamino)ethyl]imidazo[4,5-c]pyridin-4-amine |
|
 | F0L | Name: | nickel-sirohydrochlorin | Formula: | C42 H44 N4 Ni O16 | SMILES: | C[C]1(CC(O)=O)[CH](CCC(O)=O)C2=NC1=Cc3n4[Ni++][N]5C(=CC6=NC(=Cc4c(CCC(O)=O)c3CC(O)=O)C(=C6CC(O)=O)CCC(O)=O)[CH](CCC(O)=O)[C](C)(CC(O)=O)C5=C2 | InChi: | InChI=1S/C42H46N4O16.Ni/c1-41(17-39(59)60)23(5-9-35(51)52)29-14-27-21(11-37(55)56)19(3-7-33(47)48)25(43-27)13-26-20(4-8-34(49)50)22(12-38(57)58)28(44-26)15-31-42(2,18-40(61)62)24(6-10-36(53)54)30(46-31)16-32(41)45-29 | Definition date: | 2020-03-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
 | F0O | Name: | 2-chloranyl-1,3-thiazole-5-carboxylic acid | Formula: | C4 H2 Cl N O2 S | SMILES: | OC(=O)c1sc(Cl)nc1 | InChi: | InChI=1S/C4H2ClNO2S/c5-4-6-1-2(9-4)3(7)8/h1H,(H,7,8) | Definition date: | 2020-03-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 2-chloranyl-1,3-thiazole-5-carboxylic acid |
|
 | F0X | Name: | cobalt-sirohydrochlorin | Formula: | C42 H44 Co N4 O16 | SMILES: | C[C]1(CC(O)=O)[CH](CCC(O)=O)C2=NC1=Cc3n4[Co++][N]5C(=CC6=NC(=Cc4c(CCC(O)=O)c3CC(O)=O)C(=C6CC(O)=O)CCC(O)=O)[CH](CCC(O)=O)[C](C)(CC(O)=O)C5=C2 | InChi: | InChI=1S/C42H46N4O16.Co/c1-41(17-39(59)60)23(5-9-35(51)52)29-14-27-21(11-37(55)56)19(3-7-33(47)48)25(43-27)13-26-20(4-8-34(49)50)22(12-38(57)58)28(44-26)15-31-42(2,18-40(61)62)24(6-10-36(53)54)30(46-31)16-32(41)45-29 | Definition date: | 2020-03-11 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
 | PIH | Name: | iodobenzene | Formula: | C6 H5 I | SMILES: | Ic1ccccc1 | InChi: | InChI=1S/C6H5I/c7-6-4-2-1-3-5-6/h1-5H | Definition date: | 2000-07-13 | Last modified: | 2021-01-05 | Identifier: | iodobenzene |
|
 | VLS | Name: | N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]glycine | Formula: | C6 H13 N O5 | SMILES: | C(CNC(CO)(CO)CO)(O)=O | InChi: | InChI=1S/C6H13NO5/c8-2-6(3-9,4-10)7-1-5(11)12/h7-10H,1-4H2,(H,11,12) | Definition date: | 2020-08-27 | Last modified: | 2021-01-01 | Release date: | 2021-01-06 | Identifier: | N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]glycine |
|
 | VXY | Name: | 2,2-difluoroethyl (3S)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate | Formula: | C20 H25 F3 N8 O4 | SMILES: | c1c(cnc(n1)N)c3c(c(nc(N2CCOCC2)n3)NC4(CCN(C(OCC(F)F)=O)C4)CO)F | InChi: | InChI=1S/C20H25F3N8O4/c21-13(22)9-35-19(33)31-2-1-20(10-31,11-32)29-16-14(23)15(12-7-25-17(24)26-8-12)27-18(28-16)30-3-5-34-6-4-30/h7-8,13,32H,1-6,9-11H2,(H2,24,25,26)(H,27,28,29)/t20-/m0/s1 | Definition date: | 2020-09-21 | Last modified: | 2021-01-01 | Release date: | 2021-01-06 | Identifier: | 2,2-difluoroethyl (3S)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate |
|